Functional differences in the mu opioid receptor SNP 118A >G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin
Clinical and Translational Science · 2024
DOI: 10.1111/cts.13888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Casey Patrick und 7 weiteren Autor:innen. Beteiligte Einrichtung: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Receptors, Opioid, mu, Polymorphism, Single Nucleotide, beta-Arrestins, Morphine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The OPRM1 gene codes for the mu opioid receptor (MOR) and polymorphisms are associated with complex patient clinical responses. The most studied single nucleotide polymorphism (SNP) in OPRM1 is adenine (A) substituted by guanine (G) at position 118 (118A>G, rs1799971) leading to a substitution of asparagine (Asn) for aspartic acid (Asp) at position 40 in the N terminus of the resulting protein. To date, no structural explanation for the associated clinical responses resulting from the 118A>G polymorphism has been proposed. We utilized computational modeling paired with functional cellular assays to predict unstructured N‐ and C‐terminal regions of MOR‐1. Using molecular docking and post‐docking energy minimizations with morphine, we show that the extracellular substitution of Asn at position 40 alters the cytoplasmic C‐terminal conformation, while leaving the G‐protein binding interface unaffected. A real‐time BRET assay measuring G‐protein and β‐arrestin association with MOR r generated data that tested this prediction. Consistent with this in silico prediction, we show changes in morphine‐mediated β‐arrestin association with receptor variants with little change in morphine‐mediated G‐protein association comparing MOR‐1 wild type (WT) to MOR‐1 118A>G . We tested the system with different opioid agonists, the OPRM1 118A>G SNP, and different MOR splice variants (MOR‐1 and MOR‐1O). These results are consistent with the observation that patients with the 118A>G OPRM1 allele respond more readily to fentanyl than to morphine. In conclusion, the 118A>G substitution alters receptor responses to opioids through variable C‐terminal domain movements that are agonist and splice variant dependent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.
- Center for Bioinformatics & Personalized Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Rocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, Colorado, USA.
ORCID-Profile: Casey Patrick, Utibeabasi Ettah, Vu Nguyen, Krishna Mallela, Robert I Scheinman, Andrew A Monte
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Patrick, C., Ettah, U., Nguyen, V., Hart, C., Atchley, E., Mallela, K., Scheinman, R. I., & Monte, A. A. (2024). Functional differences in the mu opioid receptor SNP 118A >G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin. Clinical and Translational Science. https://doi.org/10.1111/cts.13888
Vancouver
Patrick C, Ettah U, Nguyen V, Hart C, Atchley E, Mallela K, et al. Functional differences in the mu opioid receptor SNP 118A >G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin. Clinical and Translational Science. 2024. doi:10.1111/cts.13888
BibTeX
@article{Patrick2024,
author = {Patrick, Casey and Ettah, Utibeabasi and Nguyen, Vu and Hart, Caitlin and Atchley, Evan and Mallela, Krishna and Scheinman, Robert I and Monte, Andrew A},
title = {Functional differences in the mu opioid receptor SNP 118A >G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin},
journal = {Clinical and Translational Science},
year = {2024},
doi = {10.1111/cts.13888}
}
EUVIMED